subscribe
 

Breakthrough for difficult-to-treat breast cancer

Hong Kong Baptist University scholars in world-first breakthrough for difficult-to-treat breast cancer



New blood test for the earlier diagnosis of breast cancer spread

Researchers analysed the blood of 112 breast cancer patients using samples collected as part of study



Primary human cancer cells

AMSBIO announces an extensive range of primary human cancer cells obtained directly from a variety tumour types, including breast, colon and prostate



Drug combination slows breast cancer spread

Palbociclib, and the hormone drug fulvestrant – slowed cancer growth in around two thirds of women with advanced forms of the most common type of breast cancer



Mathematics aids breast cancer research

New possibilities for the treatment of breast cancer arise, with the help of mathematics



Cutting edge breast cancer research

Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence



Sunlight reduces risk of breast cancer

Over the last few years, more and more studies have been taking a closer look at the links between sunlight and overall cancer risk.



Study links two genes to breast cancer survival

Research could be used to develop tests for aggressive breast cancers, or even to identify new targets for cancer treatment



Breast cancer: towards personalised treatment

Largest-ever study of breast cancer genomes reveals new genes and mutations involved in the disease



Gene may worsen cancer outcome by speeding metabolism of drugs

The gene, called CYP3A7, is normally only active in infancy, but in some people it continues to be switched on into adulthood



Ecologically diverse breast cancers more likely to be deadly

Scientists develop test which combines methods used by ecologists with a cancer imaging technique to pick out cancerous cells from normal cells in tumours



‘Next generation’ cancer drug shows promise in early trial

A new potential cancer drug has shown promising results in an early stage clinical trial. The drug, called AUY922, could help lead to a new way to treat a wide range of cancers including breast and lung cancer.



Unique study reveals genetic spelling mistakes that increase the risk of common cancers

More than 80 genetic ’spelling mistakes’ that can increase the risk of breast, prostate and ovarian cancer have been found in a large, international research study within the framework of the EU network COGS.



Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe